Hanna Wanas

6PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersSurface water quality processes and contaminated sediment assessmentCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 04, 2023
The impact of CYP3A4 and CYP3A5 genetic variations on tacrolimus treatment of living-donor Egyptian kidney transplanted patients.

Hanaa Wanas, Mai Hamed Kamel, Emad Adel William

|Jan 25, 2022
Prognostic factors for predicting severity and mortality in hospitalized COVID-19 patients.

Fahad Dakilallah Aljohani, Amin Khattab, Hossein M Elbadawy

|Feb 16, 2021
Nebivolol protects against cyclophosphamide-induced nephrotoxicity through modulation of oxidative stress, inflammation, and apoptosis.

Hanaa Wanas, Mohamed El-Shabrawy, Amal Mishriki

|Sep 30, 2020
Protective effect of tolvaptan against cyclophosphamide-induced nephrotoxicity in rat models.

Mohamed El-Shabrawy, Amal Mishriki, Hisham Attia

Pageof 1